Early decreases in blood eosinophil levels with reslizumab

J Allergy Clin Immunol. 2019 Apr;143(4):1653-1655. doi: 10.1016/j.jaci.2018.12.997. Epub 2019 Jan 14.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / blood
  • Asthma / drug therapy*
  • Eosinophilia / blood
  • Eosinophilia / drug therapy*
  • Eosinophils / drug effects*
  • Female
  • Humans
  • Male
  • Middle Aged

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • reslizumab